ZURNAI (AUTOINJECTOR) Drug Patent Profile

✉ Email this page to a colleague

When do Zurnai (autoinjector) patents expire, and when can generic versions of Zurnai (autoinjector) launch?

Zurnai (autoinjector) is a drug marketed by Purdue Pharma Lp and is included in one NDA. There are twenty-one patents protecting this drug.

This drug has sixty-eight patent family members in fourteen countries.

The generic ingredient in ZURNAI (AUTOINJECTOR) is nalmefene hydrochloride. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the nalmefene hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Zurnai (autoinjector)

A generic version of ZURNAI (AUTOINJECTOR) was approved as nalmefene hydrochloride by PURDUE PHARMA LP on February 8^th, 2022.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for ZURNAI (AUTOINJECTOR)?
What are the global sales for ZURNAI (AUTOINJECTOR)?
What is Average Wholesale Price for ZURNAI (AUTOINJECTOR)?

Summary for ZURNAI (AUTOINJECTOR)

International Patents:	68
US Patents:	21
Applicants:	1
NDAs:	1
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for ZURNAI (AUTOINJECTOR)
DailyMed Link:	ZURNAI (AUTOINJECTOR) at DailyMed

Drug patent expirations by year for ZURNAI (AUTOINJECTOR)

US Patents and Regulatory Information for ZURNAI (AUTOINJECTOR)

ZURNAI (AUTOINJECTOR) is protected by twenty-one US patents and one FDA Regulatory Exclusivity.

Patents protecting ZURNAI (AUTOINJECTOR)

Injection device with cammed RAM assembly
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Needle assisted jet injection device having reduced trigger force
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Prefilled syringe injector
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Needle assisted injection device having reduced trigger force
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Injection device with cammed ram assembly
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Syringe shock absorber for use in an injection device
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Prefilled syringe injector
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATING OPIOID OVERDOSE

Prefilled syringe jet injector
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Injection device with cammed ram assembly
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Prefilled syringe jet injector
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Injection device with cammed ram assembly
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Needle assisted jet injection device having reduced trigger force
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Injection device with cammed ram assembly
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Prefilled syringe jet injector
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

FDA Regulatory Exclusivity protecting ZURNAI (AUTOINJECTOR)

NEW PRODUCT
Exclusivity Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Purdue Pharma Lp	ZURNAI (AUTOINJECTOR)	nalmefene hydrochloride	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	218590-001	Aug 7, 2024		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Purdue Pharma Lp	ZURNAI (AUTOINJECTOR)	nalmefene hydrochloride	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	218590-001	Aug 7, 2024		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Purdue Pharma Lp	ZURNAI (AUTOINJECTOR)	nalmefene hydrochloride	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	218590-001	Aug 7, 2024		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Purdue Pharma Lp	ZURNAI (AUTOINJECTOR)	nalmefene hydrochloride	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	218590-001	Aug 7, 2024		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for ZURNAI (AUTOINJECTOR)

See the table below for patents covering ZURNAI (AUTOINJECTOR) around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Spain	2886553		⤷ Sign Up
Canada	2595730	INJECTEUR A SERINGUE PREREMPLIE ASSISTE D'UNE AIGUILLE (PREFILLED NEEDLE ASSISTED JET INJECTOR)	⤷ Sign Up
Japan	2008528126		⤷ Sign Up
European Patent Office	2833944	ADMINISTRATION PAR INJECTION PAR JET ASSISTÉE PAR UNE AIGUILLE DE COMPOSITIONS DE TESTOSTÉRONE (NEEDLE ASSISTED JET INJECTION ADMINISTRATION OF TESTOSTERONE COMPOSITIONS)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for ZURNAI (AUTOINJECTOR)

Patents protecting ZURNAI (AUTOINJECTOR)

FDA Regulatory Exclusivity protecting ZURNAI (AUTOINJECTOR)

Make Better Decisions: Try a trial or see plans & pricing